Zinc Acetate Dihydrate
Dystonic Disorder
Children's University Hospital Cologne, GermanyUNKNOWNPhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Dystonic Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dexdomitor Vanderbilt University | Phase 2/3 | B |
Mtr-601 Motric Bio | Phase 1 | CC |
Same molecule, other indications
Zinc Acetate Dihydrate is also rated in:
global developmental delay with or without impaired intellectual developmentActive
B
Indicative · Phase 2
57 / 100
View asset →neurodevelopmental disorder with involuntary movementsActive
NR
Indicative · Phase 2
/ 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →